THEUER CHARLES bought FDMT
December 12, 2025 · Form 4 insider transaction
THEUER CHARLES bought 9,333 shares of 4D Molecular Therapeutics, Inc. at $1.14 per share, a transaction worth $10.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
9,333
Price
$1.14
Total value
$10.6K
InsiderTHEUER CHARLES
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 12, 2025
Filing dateDecember 16, 2025
Shares owned after41,684
OwnershipDirect
10b5-1 planNo
AmendedNo